Published in Lancet Infect Dis on October 01, 2006
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2013) 5.78
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2014) 5.14
HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev (2011) 3.28
Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One (2008) 3.07
The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study. PLoS Med (2010) 2.86
Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med (2007) 2.71
Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study. PLoS One (2011) 2.40
Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med (2011) 2.14
Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med (2011) 2.02
Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis (2009) 1.92
Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis (2009) 1.92
Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev (2009) 1.87
Evidence-based tuberculosis diagnosis. PLoS Med (2008) 1.82
Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol (2008) 1.80
Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One (2008) 1.59
New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev (2010) 1.57
Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. Am J Respir Crit Care Med (2009) 1.54
Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study. PLoS One (2010) 1.54
Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis? J Clin Microbiol (2010) 1.35
Choosing algorithms for TB screening: a modelling study to compare yield, predictive value and diagnostic burden. BMC Infect Dis (2014) 1.34
Diagnosis & treatment of tuberculosis in HIV co-infected patients. Indian J Med Res (2011) 1.30
Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa. J Acquir Immune Defic Syndr (2011) 1.24
Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis. PLoS One (2015) 1.21
Simple measures are as effective as invasive techniques in the diagnosis of pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis (2009) 1.20
Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ (2007) 1.19
Autofluorescence of mycobacteria as a tool for detection of Mycobacterium tuberculosis. J Clin Microbiol (2008) 1.16
Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol (2008) 1.16
Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States. Int J Tuberc Lung Dis (2013) 1.15
Computer-aided detection and quantification of cavitary tuberculosis from CT scans. Med Phys (2013) 1.14
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples. J Clin Microbiol (2012) 1.13
High sensitivity and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in an African population with a high prevalence of human immunodeficiency virus. J Clin Microbiol (2009) 1.12
Comparative meta-analysis of tuberculosis contact investigation interventions in eleven high burden countries. PLoS One (2015) 1.10
Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis (2013) 1.09
Research questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analyses. PLoS One (2012) 1.09
Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings. J Clin Microbiol (2010) 1.09
Infection control knowledge, attitudes, and practices among healthcare workers in Addis Ababa, Ethiopia. Infect Control Hosp Epidemiol (2013) 1.08
Use of colorimetric culture methods for detection of Mycobacterium tuberculosis complex isolates from sputum samples in resource-limited settings. J Clin Microbiol (2013) 1.08
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis (2008) 1.07
Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clin Vaccine Immunol (2011) 1.04
Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana-findings from the DETECT HIV-TB study. BMC Infect Dis (2015) 1.04
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis (2012) 1.03
HIV-related incremental yield of bleach sputum concentration and fluorescence technique for the microscopic detection of tuberculosis. Eur J Clin Microbiol Infect Dis (2008) 1.02
Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev (2011) 1.01
Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. PLoS One (2014) 1.00
Comparison of LED and conventional fluorescence microscopy for detection of acid fast bacilli in a low-incidence setting. PLoS One (2011) 1.00
Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa. PLoS One (2013) 0.99
Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study. BMC Infect Dis (2010) 0.98
Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis. J Clin Microbiol (2014) 0.96
Increased sensitivity in diagnosis of tuberculosis in HIV-positive patients through the small-membrane-filter method of microscopy. J Clin Microbiol (2013) 0.95
Population-level impact of active tuberculosis case finding in an Asian megacity. PLoS One (2013) 0.95
Implementation of LED fluorescence microscopy for diagnosis of pulmonary and HIV-associated tuberculosis in a hospital setting in Indonesia. PLoS One (2013) 0.94
Evaluation of combined LED-fluorescence microscopy and bleach sedimentation for diagnosis of tuberculosis at peripheral health service level. PLoS One (2011) 0.94
A novel multiplex real-time PCR for the identification of mycobacteria associated with zoonotic tuberculosis. PLoS One (2011) 0.93
Serological tests for the diagnosis of active tuberculosis: relevance for India. Indian J Med Res (2012) 0.93
Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis (2009) 0.91
Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection. Am J Respir Crit Care Med (2010) 0.90
Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis. J Clin Microbiol (2013) 0.89
Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy. BMC Infect Dis (2011) 0.88
Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting. PLoS One (2014) 0.85
Direct microscopy versus sputum cytology analysis and bleach sedimentation for diagnosis of tuberculosis: a prospective diagnostic study. BMC Infect Dis (2010) 0.85
High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria. PLoS One (2013) 0.84
Evaluation of bleach-sedimentation for sterilising and concentrating Mycobacterium tuberculosis in sputum specimens. BMC Infect Dis (2011) 0.84
A pilot study of short-duration sputum pretreatment procedures for optimizing smear microscopy for tuberculosis. PLoS One (2009) 0.83
A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis. Elife (2014) 0.82
Selection and application of ssDNA aptamers to detect active TB from sputum samples. PLoS One (2012) 0.82
Operational implementation of LED fluorescence microscopy in screening tuberculosis suspects in an urban HIV clinic in Uganda. PLoS One (2013) 0.82
UV-fixed-thick-blotch preparation improves sensitivity of auramine staining. J Clin Microbiol (2013) 0.81
Tuberculosis: time for a new perspective? J Infect (2013) 0.81
Effects of different methods of decontamination for successful cultivation of Mycobacterium tuberculosis. Indian J Med Res (2013) 0.81
Single-Stranded DNA Aptamers against Pathogens and Toxins: Identification and Biosensing Applications. Biomed Res Int (2015) 0.81
Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa. PLoS One (2015) 0.81
Evaluation of Giant African Pouched Rats for Detection of Pulmonary Tuberculosis in Patients from a High-Endemic Setting. PLoS One (2015) 0.80
Integrated therapy for HIV and tuberculosis. AIDS Res Ther (2016) 0.80
Validity of serum adenosine deaminase in diagnosis of tuberculosis. Pan Afr Med J (2013) 0.79
Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda. PLoS One (2014) 0.78
Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B. BMC Biotechnol (2014) 0.78
The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis. Sci Rep (2015) 0.78
Novel phage display-derived mycolic acid-specific antibodies with potential for tuberculosis diagnosis. J Lipid Res (2013) 0.78
Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology. PLoS One (2015) 0.78
A comparison of tools used for tuberculosis diagnosis in resource-limited settings: a case study at Mubende referral hospital, Uganda. PLoS One (2014) 0.78
Detection of Mycobacterium tuberculosis based on H37R(v) binding peptides using surface functionalized magnetic microspheres coupled with quantum dots – a nano detection method for Mycobacterium tuberculosis. Int J Nanomedicine (2014) 0.78
Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India. PLoS One (2015) 0.78
The implications of whole-genome sequencing in the control of tuberculosis. Ther Adv Infect Dis (2015) 0.77
A novel B-cell epitope identified within Mycobacterium tuberculosis CFP10/ESAT-6 protein. PLoS One (2013) 0.77
Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design. PLoS One (2016) 0.77
Diagnostic Accuracy of the Small Membrane Filtration Method for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Prevalence Setting. J Clin Microbiol (2016) 0.77
An Update on Global Tuberculosis (TB). Infect Dis (Auckl) (2013) 0.77
Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana. Int J Mycobacteriol (2017) 0.76
Standardization of a TaqMan-based real-time PCR for the detection of Mycobacterium tuberculosis-complex in human sputum. Am J Trop Med Hyg (2014) 0.76
A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis. PLoS One (2014) 0.76
Is bleach-sedimented smear microscopy an alternative to direct microscopy under programme conditions in India? Public Health Action (2013) 0.76
External quality assessment for acid fast bacilli smear microscopy in eastern part of Ethiopia. BMC Res Notes (2015) 0.76
Microchip-based ultrafast serodiagnostic assay for tuberculosis. Sci Rep (2016) 0.75
Tuberculosis diagnostics: Challenges and opportunities. Lung India (2012) 0.75
Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis. Saudi Med J (2016) 0.75
Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania. PLoS One (2016) 0.75
Performance of the BacT Alert 3D System Versus Solid Media for Recovery and Drug Susceptibility Testing of Mycobacterium tuberculosis in a Tertiary Hospital in Korea. Tuberc Respir Dis (Seoul) (2016) 0.75
Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi. Trans R Soc Trop Med Hyg (2016) 0.75
Magnetic Multivalent Trehalose Glycopolymer Nanoparticles for the Detection of Mycobacteria. Adv Healthc Mater (2016) 0.75
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med (2003) 14.40
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis (2006) 9.35
Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 8.90
Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med (2007) 8.81
Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis (2007) 6.40
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2013) 5.78
Clinical practice. Latent tuberculosis infection. N Engl J Med (2002) 5.64
Diagnostics for the developing world. Nat Rev Microbiol (2004) 5.62
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med (2002) 5.42
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2011) 5.34
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med (2011) 5.25
Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med (2007) 5.20
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2014) 5.14
Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med (2006) 4.96
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet (2010) 4.71
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
International standards for tuberculosis care. Lancet Infect Dis (2006) 4.67
Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J Clin Microbiol (2010) 4.54
Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest (2008) 4.41
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med (2011) 4.21
Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis (2008) 4.14
T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis (2007) 3.96
Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2010) 3.83
Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature (2006) 3.72
Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med (2007) 3.32
Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis (2003) 3.27
Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med (2012) 3.26
Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One (2008) 3.07
Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. Clin Infect Dis (2014) 3.07
A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis (2005) 3.05
Tuberculosis diagnosis--time for a game change. N Engl J Med (2010) 2.96
New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med (2010) 2.92
Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol (2007) 2.85
Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med (2012) 2.84
Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2012) 2.80
Bridging the gap between knowledge and health: the epidemiologist as Accountable Health Advocate ("AHA!"). Epidemiology (2012) 2.74
Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med (2007) 2.71
Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther (2007) 2.62
Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med (2009) 2.61
Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis (2010) 2.61
Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax (2011) 2.61
Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect (2006) 2.59
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (2011) 2.59
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med (2009) 2.55
Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med (2008) 2.52
Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis (2013) 2.41
The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med (2007) 2.39
A multi-country non-inferiority cluster randomized trial of frontloaded smear microscopy for the diagnosis of pulmonary tuberculosis. PLoS Med (2011) 2.38
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis (2009) 2.36
T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med (2009) 2.34
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One (2009) 2.34
Tuberculosis control: business models for the private sector. Lancet Infect Dis (2012) 2.32
Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis (2009) 2.25
In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol (2005) 2.24
Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med (2011) 2.24
Risk factors for acute myocardial infarction in a rural population of central India: a hospital-based case-control study. Natl Med J India (2004) 2.23
High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med (2010) 2.23
Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. Ophthalmology (2007) 2.17
Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med (2011) 2.14
Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A (2010) 2.12
Laboratory diagnostic aspects of drug resistant tuberculosis. Front Biosci (2004) 2.07
Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg (2006) 2.04
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2006) 2.04
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2010) 2.04
Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One (2010) 2.03
Systematic reviews of diagnostic test evaluations: What's behind the scenes? ACP J Club (2004) 2.02
Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med (2011) 2.02
Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med (2008) 1.96
Integrated strategies to optimize sputum smear microscopy: a prospective observational study. Am J Respir Crit Care Med (2010) 1.95
The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med (2011) 1.95
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2011) 1.95
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med (2009) 1.95
Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS One (2007) 1.94
Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc (2006) 1.94
Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis (2009) 1.92
T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One (2008) 1.91